Vertex Pharmaceuticals VRTX reported its Q3 earnings results on Tuesday, November 2, 2021 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Vertex Pharmaceuticals their estimated earnings by 15.58%, reporting an EPS of $3.56 versus an estimate of $3.08, which surprised analysts.
Revenue was up $446,000,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.83, which was followed by a 0.6% increase in the share price the next day.
Here's a look at Vertex Pharmaceuticals's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | 2.28 | 2.69 | 2.59 | 2.32 |
EPS Actual | 3.11 | 2.98 | 2.51 | 2.64 |
Revenue Estimate | 1.72B | 1.66B | 1.58B | 1.47B |
Revenue Actual | 1.79B | 1.72B | 1.63B | 1.54B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.